Boston Trust Walden’s Kadant KAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-35,816
Closed -$3.93M 377
2020
Q3
$3.93M Sell
35,816
-113,762
-76% -$12.9M 0.05% 244
2020
Q2
$14.9M Buy
149,578
+12,877
+9% +$1.15M 0.2% 162
2020
Q1
$10.2M Buy
136,701
+4,319
+3% +$409K 0.16% 177
2019
Q4
$13.9M Buy
132,382
+2,807
+2% +$267K 0.16% 179
2019
Q3
$11.4M Buy
129,575
+1,034
+0.8% +$88.7K 0.14% 192
2019
Q2
$11.7M Sell
128,541
-1,789
-1% -$161K 0.15% 178
2019
Q1
$11.5M Buy
130,330
+2,850
+2% +$245K 0.16% 175
2018
Q4
$10.4M Sell
127,480
-6,298
-5% -$590K 0.17% 170
2018
Q3
$14.4M Sell
133,778
-7,156
-5% -$711K 0.2% 142
2018
Q2
$13.6M Sell
140,934
-3,310
-2% -$318K 0.2% 145
2018
Q1
$13.6M Buy
144,244
+45,330
+46% +$4.45M 0.21% 138
2017
Q4
$9.93M Sell
98,914
-1,957
-2% -$199K 0.15% 187
2017
Q3
$9.94M Buy
100,871
+315
+0.3% +$26.7K 0.15% 183
2017
Q2
$7.56M Buy
+100,556
New +$7.01M 0.12% 196

Other funds holding KAI

Boston Trust Walden's KAI Position: Q4 2020 in Review

Boston Trust Walden sold out of Kadant (KAI) in Q4 2020, closing a stake of 35,816 shares — an estimated $3.93M sold.

Boston Trust Walden first reported a position in KAI in Q2 2017 and held it in 14 quarters. The position peaked at $14.9M in Q2 2020. 149 funds tracked by Wall St. Rank hold KAI as of Q4 2020.

  • Boston Trust Walden reported no remaining Kadant position as of Q4 2020 after selling out during the quarter.
  • Boston Trust Walden sold 35,816 Kadant shares in Q4 2020, an estimated $3.93M.
  • Boston Trust Walden first reported a position in Kadant in Q2 2017 and held it in 14 quarters.
  • Boston Trust Walden's Kadant position peaked at $14.9M in Q2 2020.
  • 149 funds tracked by Wall St. Rank held Kadant as of Q4 2020.

Based on Boston Trust Walden's 13F filing for Q4 2020, filed 15 Jan 2021.